Cargando…
Clinical significance of the combination of preoperative SUVmax and CEA in patients with clinical stage IA lung adenocarcinoma
BACKGROUND: Preoperative maximum standardized uptake value (SUVmax) of 2‐[18F]‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography and serum carcinoembryonic antigen (CEA) have been reported as prognostic factors for lung adenocarcinoma. However, the significance of combined SUVmax and CEA in earl...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475234/ https://www.ncbi.nlm.nih.gov/pubmed/35962578 http://dx.doi.org/10.1111/1759-7714.14599 |
_version_ | 1784789868697616384 |
---|---|
author | Hashinokuchi, Asato Haratake, Naoki Takenaka, Tomoyoshi Matsudo, Kyoto Nagano, Taichi Watanabe, Kenji Kosai, Keisuke Oku, Yuka Ono, Yuki Takamori, Shinkichi Kohno, Mikihiro Baba, Shingo Ishigami, Kousei Yoshizumi, Tomoharu |
author_facet | Hashinokuchi, Asato Haratake, Naoki Takenaka, Tomoyoshi Matsudo, Kyoto Nagano, Taichi Watanabe, Kenji Kosai, Keisuke Oku, Yuka Ono, Yuki Takamori, Shinkichi Kohno, Mikihiro Baba, Shingo Ishigami, Kousei Yoshizumi, Tomoharu |
author_sort | Hashinokuchi, Asato |
collection | PubMed |
description | BACKGROUND: Preoperative maximum standardized uptake value (SUVmax) of 2‐[18F]‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography and serum carcinoembryonic antigen (CEA) have been reported as prognostic factors for lung adenocarcinoma. However, the significance of combined SUVmax and CEA in early‐stage lung adenocarcinoma is not well known. METHODS: We retrospectively evaluated the relationship between the combination of SUVmax and CEA and the prognosis of 410 patients with clinical stage IA lung adenocarcinoma who underwent resection. The cutoff values for SUVmax and CEA were determined by receiver operating characteristic curve analysis, and patients were categorized into high SC (SUVmax and CEA) group (SUVmax ≥2.96 and CEA ≥5.3), moderate SC group (either SUVmax <2.96 and CEA ≥5.3 or SUVmax ≥2.96 and CEA <5.3) and low SC group (SUVmax <2.96 and CEA <5.3). RESULTS: Kaplan–Meier curve analysis showed that patients with clinical stage IA lung adenocarcinoma in the high SC group had significantly shorter overall survival (OS) and recurrence‐free survival (RFS) than the other groups (p = 0.011 and p < 0.0001, respectively). Multivariate analysis showed that high SC was an independent prognostic factor of OS (p = 0.029) and RFS (p < 0.0001). CONCLUSIONS: High values of SUVmax and CEA were associated with poor OS and RFS in patients with stage IA lung adenocarcinoma. Simultaneous evaluation of SUVmax and CEA may be an effective prognostic marker to determine the optimal treatment strategy of early‐stage lung adenocarcinoma. |
format | Online Article Text |
id | pubmed-9475234 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley & Sons Australia, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-94752342022-09-28 Clinical significance of the combination of preoperative SUVmax and CEA in patients with clinical stage IA lung adenocarcinoma Hashinokuchi, Asato Haratake, Naoki Takenaka, Tomoyoshi Matsudo, Kyoto Nagano, Taichi Watanabe, Kenji Kosai, Keisuke Oku, Yuka Ono, Yuki Takamori, Shinkichi Kohno, Mikihiro Baba, Shingo Ishigami, Kousei Yoshizumi, Tomoharu Thorac Cancer Original Articles BACKGROUND: Preoperative maximum standardized uptake value (SUVmax) of 2‐[18F]‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography and serum carcinoembryonic antigen (CEA) have been reported as prognostic factors for lung adenocarcinoma. However, the significance of combined SUVmax and CEA in early‐stage lung adenocarcinoma is not well known. METHODS: We retrospectively evaluated the relationship between the combination of SUVmax and CEA and the prognosis of 410 patients with clinical stage IA lung adenocarcinoma who underwent resection. The cutoff values for SUVmax and CEA were determined by receiver operating characteristic curve analysis, and patients were categorized into high SC (SUVmax and CEA) group (SUVmax ≥2.96 and CEA ≥5.3), moderate SC group (either SUVmax <2.96 and CEA ≥5.3 or SUVmax ≥2.96 and CEA <5.3) and low SC group (SUVmax <2.96 and CEA <5.3). RESULTS: Kaplan–Meier curve analysis showed that patients with clinical stage IA lung adenocarcinoma in the high SC group had significantly shorter overall survival (OS) and recurrence‐free survival (RFS) than the other groups (p = 0.011 and p < 0.0001, respectively). Multivariate analysis showed that high SC was an independent prognostic factor of OS (p = 0.029) and RFS (p < 0.0001). CONCLUSIONS: High values of SUVmax and CEA were associated with poor OS and RFS in patients with stage IA lung adenocarcinoma. Simultaneous evaluation of SUVmax and CEA may be an effective prognostic marker to determine the optimal treatment strategy of early‐stage lung adenocarcinoma. John Wiley & Sons Australia, Ltd 2022-08-12 2022-09 /pmc/articles/PMC9475234/ /pubmed/35962578 http://dx.doi.org/10.1111/1759-7714.14599 Text en © 2022 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Hashinokuchi, Asato Haratake, Naoki Takenaka, Tomoyoshi Matsudo, Kyoto Nagano, Taichi Watanabe, Kenji Kosai, Keisuke Oku, Yuka Ono, Yuki Takamori, Shinkichi Kohno, Mikihiro Baba, Shingo Ishigami, Kousei Yoshizumi, Tomoharu Clinical significance of the combination of preoperative SUVmax and CEA in patients with clinical stage IA lung adenocarcinoma |
title | Clinical significance of the combination of preoperative SUVmax and CEA in patients with clinical stage IA lung adenocarcinoma |
title_full | Clinical significance of the combination of preoperative SUVmax and CEA in patients with clinical stage IA lung adenocarcinoma |
title_fullStr | Clinical significance of the combination of preoperative SUVmax and CEA in patients with clinical stage IA lung adenocarcinoma |
title_full_unstemmed | Clinical significance of the combination of preoperative SUVmax and CEA in patients with clinical stage IA lung adenocarcinoma |
title_short | Clinical significance of the combination of preoperative SUVmax and CEA in patients with clinical stage IA lung adenocarcinoma |
title_sort | clinical significance of the combination of preoperative suvmax and cea in patients with clinical stage ia lung adenocarcinoma |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475234/ https://www.ncbi.nlm.nih.gov/pubmed/35962578 http://dx.doi.org/10.1111/1759-7714.14599 |
work_keys_str_mv | AT hashinokuchiasato clinicalsignificanceofthecombinationofpreoperativesuvmaxandceainpatientswithclinicalstageialungadenocarcinoma AT haratakenaoki clinicalsignificanceofthecombinationofpreoperativesuvmaxandceainpatientswithclinicalstageialungadenocarcinoma AT takenakatomoyoshi clinicalsignificanceofthecombinationofpreoperativesuvmaxandceainpatientswithclinicalstageialungadenocarcinoma AT matsudokyoto clinicalsignificanceofthecombinationofpreoperativesuvmaxandceainpatientswithclinicalstageialungadenocarcinoma AT naganotaichi clinicalsignificanceofthecombinationofpreoperativesuvmaxandceainpatientswithclinicalstageialungadenocarcinoma AT watanabekenji clinicalsignificanceofthecombinationofpreoperativesuvmaxandceainpatientswithclinicalstageialungadenocarcinoma AT kosaikeisuke clinicalsignificanceofthecombinationofpreoperativesuvmaxandceainpatientswithclinicalstageialungadenocarcinoma AT okuyuka clinicalsignificanceofthecombinationofpreoperativesuvmaxandceainpatientswithclinicalstageialungadenocarcinoma AT onoyuki clinicalsignificanceofthecombinationofpreoperativesuvmaxandceainpatientswithclinicalstageialungadenocarcinoma AT takamorishinkichi clinicalsignificanceofthecombinationofpreoperativesuvmaxandceainpatientswithclinicalstageialungadenocarcinoma AT kohnomikihiro clinicalsignificanceofthecombinationofpreoperativesuvmaxandceainpatientswithclinicalstageialungadenocarcinoma AT babashingo clinicalsignificanceofthecombinationofpreoperativesuvmaxandceainpatientswithclinicalstageialungadenocarcinoma AT ishigamikousei clinicalsignificanceofthecombinationofpreoperativesuvmaxandceainpatientswithclinicalstageialungadenocarcinoma AT yoshizumitomoharu clinicalsignificanceofthecombinationofpreoperativesuvmaxandceainpatientswithclinicalstageialungadenocarcinoma |